Key result
The K15N mutation in tropomyosin desensitizes thin filaments to Ca2+, while the R21H mutation causes a twofold decrease in tropomyosin's affinity for F-actin and alters leiomodin's function.
Why the study?
Missense mutations K15N and R21H in striated muscle tropomyosin are linked to DCM and HCM, but their effects on thin-filament regulation and pointed-end dynamics were unclear.
The K15N mutation alters Ca2+-dependent thin-filament regulation leading to dilated cardiomyopathy, while the R21H mutation alters leiomodin's function, suggesting a mechanism for hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
These mutation effects suggest distinct cardiomyopathy pathways; hypothesis-generating and requires human validation before any clinical consideration.
Ly et al. (2018) studied Dilated cardiomyopathy and hypertrophic cardiomyopathy (in vitro models). Tropomyosin mutations K15N and R21H vs. Wild-type tropomyosin (WT Tpm1.1) was evaluated on Ca2+ sensitivity and binding affinity to F-actin. The K15N mutation in tropomyosin desensitizes thin filaments to Ca2+, while the R21H mutation causes a twofold decrease in tropomyosin's affinity for F-actin and alters leiomodin's function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: